维普中文期刊产品整合服务
371篇 您的检索式:作者名="Hur C"
    题名 作者 年代 出处 被引量
1High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis显示文摘AIM:To study the cost-effectiveness of high-resolution microendoscopy(HRME)in an esophageal squamous cell carcinoma(ESCC)screening program in China.METHODS:A decision analytic Markov model of ESCC was developed.Separate model analyses were conducted for cohorts consisting of an averagerisk population or a high-risk population in China.Hypothetical 50-year-old individuals were followed until age 80 or death.We compared three different strategies for both cohorts:(1)no screening;(2)standard endoscopic screening with Lugol’s iodine staining;and(3)endoscopic screening with Lugol’s iodine staining and an HRME.Model parameters were estimated from the literature as well as from GLOBOCAN,the Cancer Incidence and Mortality Worldwide cancer database.Health states in the model included non-neoplasia,mild dysplasia,moderate dysplasia,high-grade dysplasia,intramucosal carcinoma,operable cancer,inoperable cancer,and death.Separate ESCC incidence transition rates were generated for the average-risk and high-risk populations.Costs in Chinese currency were converted to international dollars(I$)and were adjusted to 2012dollars using the Consumer Price Index.RESULTS:The main outcome measurements for this study were quality-adjusted life years(QALYs)and incremental cost-effectiveness ratio(ICER).For the average-risk population,the HRME screening strategy produced 0.043 more QALYs than the no screening strategy at an additional cost of I$646,resulting in an ICER of I$11808 per QALY gained.Standard endoscopic screening was weakly dominated.Among the high-risk population,when the HRME screening strategy was compared with the standard screening strategy,the ICER was I$8173 per QALY.For both the high-risk and average-risk screening populations,the HRME screening strategy appeared to be the most cost-effective strategy,producing ICERs below the willingness-topay threshold,I$23500 per QALY.One-way sensitivity analysis showed that,for the average-risk population,higher specificity of Lugol’s iodine(>40%)and lower specificity of HRME(<70%)could make Lugol’s iodine screening cost-effective.For the high-risk population,the results of the model were not substantially affected by varying the follow-up rate after Lugol’s iodine screening,Lugol’s iodine test characteristics(sensitivity and specificity),or HRME specificity.CONCLUSION:The incorporation of HRME into an ESCC screening program could be cost-effective in China.Larger studies of HRME performance are needed to confirm these findings.Chin Hur Sung Eun Choi Chung Yin Kong Gui-Qi Wang Hong Xu Alexandros D Polydorides Li-Yan Xue Katherine E Perzan Angela C Tramontano Rebecca R Richards-Kortum Sharmila Anandasabapathy 2015World Journal of Gastroenterology2015,21,18:8
2MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis显示文摘Keun Hur Yuji Toiyama Masanobu Takahashi Francesc Balaguer Takeshi Nagasaka Junichi Koike Hiromichi Hemmi Minoru Koi C Richard Boland Ajay Goel 2013Gut2013,,9:6
3ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome 显示文摘Ginestier C Hur MH CharafeJanffret E 2007Cell Stem Ce112007,1,5:1
4ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor elinical outcome显示文摘Ginestier C Hur MH Charafe-Jauffret E 2007Cell Stem Cell2007,1,5:1
5ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome显示文摘Ginestier C Hur MH Charafe-Jauffret E 0,,05:1
6Monitoring of selected veterinary antibiotics in environmental compartments near a composting facility in Gangwon Province,Korea显示文摘Ok Y S Kim S C Kim K R Lee S S Moon D H Lim K J Sung J K Hur S O Yang J E 0,,:1
7Evidence-based endoscopic management of Barrett's esophagus显示文摘Yachimski P Hur C 2014Gastroenterol Rep (Oxf)2014,,:1
8ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome显示文摘GINESTIER C HUR M H CHARAFE-JAUFFRET E 2007Cell Stem Cell2007,1,5:1
9ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome显示文摘Ginestier C Hur MH Charfe-Jauffret E 2007Cell Stem Cell2007,1,5:1
10Current and potential renal applications of contrast-enhanced ultrasound 显示文摘McA1~hur C Baxter GM 2012Clin Radiol2012,67,9:1
11Effect of dietary conjugated linoleic acid, irradiation, and packaging conditions on the quality characteristic of raw broiler breast fillets显示文摘DU M NAM K C HUR S J 2002Meat Science2002,60,1:1
12ALDH1 is a marker of normal and malignant breast stem cells and a predictor of poor clinical outcome显示文摘Ginestier C Hur M Charafe-Jauffret E 2007Cell Stem Cell2007,1,5:1
13Hot corrosion behavior of Ni-base alloys in a molten salt under an oxidi- zing atmosphere 显示文摘Cho S H Hur J M Seo C S 2009Journal of Alloys and Compounds2009,468,12:1
14Characterization of a ricechlorophyll-deficient mutant using the T-DNA gene-trap system显示文摘Jung K H Hur J Ryu C H 2003Plant Cell Physiol2003,44,5:1
15ALDH1 is a mar- ker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome显示文摘Ginestier C Hur MH Charafe-Jauffret E 2007Cell Stem Cell2007,1,5:1
16Upregulation of FLIP(S)by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers 显示文摘Nam S Y Jung G A Hur G C 2003Cancer Sci2003,94,12:1
17Transition state stabilization bygeneral acid catalysis, water expulsion, and enzyme reorgani-zation in Medicago savita chalcone isomerase 显示文摘Hur S Newby Z E Bruice T C 2004Proc NatlAcad Sci2004,101,9:1
18Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells显示文摘YOON C H HUR J OH I Y 2006Arterioscler Thromb Vasc Biol2006,26,:1
19High temperature corrosion of superalloys in a molten salt under an oxi- dizing atmosphere显示文摘Cho S H Hur J M Seo C S 2008Journal of Alloys and Compounds2008,452,1:1
20ALDH1 is amarker of normal and malignant human mammary stem cellsand a predictor of poor clinical outcome显示文摘Ginestier C Hur M H Charafe-Jauffret E 2007Cell Stem Cell2007,1,5:1
返回顶部 每页显示:
共19页 首页 上一页 第1页 下一页 末页 /19 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费